Viatris(VTRS) GlobeNewswire News Room·2025-04-14 00:42Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Viatris Inc. securities during the specified Class Period, indicating potential legal issues related to the company's disclosures and the impact of regulatory actions on its financials [1][5]. Group 1: Class Action Details - The class action lawsuit is filed for securities purchased between August 8, 2024, and February 26, 2025, and investors may be entitled to compensation without upfront costs through a contingency fee arrangement [2][3]. - Investors wishing to serve as lead plaintiff must file a motion by June 3, 2025, and a lead plaintiff acts on behalf of other class members in directing the litigation [3]. Group 2: Allegations Against Viatris - The lawsuit claims that during the Class Period, Viatris provided misleading information regarding the failed inspection of its Indore, India facility, including the issuance of an FDA warning letter that restricted the shipment of eleven products [5][6]. - Defendants allegedly downplayed the significance of the warning letter, referring to it as a "minor headwind," while failing to disclose critical details about the inspection timeline, remediation efforts, and the financial implications of the warning letter on Viatris' operations [6]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes its experience and success in securities class actions, having achieved significant settlements and recognition in the field, including being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone, showcasing its capability to represent investors effectively [4].